First ‘off-the-shelf’ stem cell therapy gains central authorization in EU – The Pharma Letter
The Pharma Letter |
First 'off-the-shelf' stem cell therapy gains central authorization in EU
The Pharma Letter Japanese pharma company Takeda Pharmaceutical (TYO: 4502) and the Belgian biopharma that it is in the process of acquiring, TiGenix, achieved a notable milestone on Friday with the European Commission's approval of Alofisel (darvadstrocel). It has been … Stem cell therapy approved in Europe to treat fistulizing Crohn's disease |
